Language:
English
繁體中文
Help
圖資館首頁
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Isolation and molecular characteriza...
~
Magbanua, Mark Jesus M.
Isolation and molecular characterization of circulating tumor cells
Record Type:
Electronic resources : Monograph/item
Title/Author:
Isolation and molecular characterization of circulating tumor cellsedited by Mark Jesus M. Magbanua, John W. Park.
other author:
Magbanua, Mark Jesus M.
Published:
Cham :Springer International Publishing :2017.
Description:
xvi, 301 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
Subject:
Metastasis.
Online resource:
http://dx.doi.org/10.1007/978-3-319-55947-6
ISBN:
9783319559476$q(electronic bk.)
Isolation and molecular characterization of circulating tumor cells
Isolation and molecular characterization of circulating tumor cells
[electronic resource] /edited by Mark Jesus M. Magbanua, John W. Park. - Cham :Springer International Publishing :2017. - xvi, 301 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.9940065-2598 ;. - Advances in experimental medicine and biology ;946..
Preface -- Circulating Tumor Cells as Cancer Biomarkers -- Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells -- Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics -- Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors -- Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis -- Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration -- Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype -- Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures -- Detection of Gene-Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer -- Enrichment, Isolation, and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells -- Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
The past decade has seen remarkable progress in elucidating the clinical relevance of circulating tumor cells (CTCs) Evidence from numerous clinical studies has unequivocally demonstrated the importance of CTCs as harbingers of poor outcome. Despite these advances, the molecular nature of CTCs remains elusive. This is in part due to the difficulty in isolating pure CTCs away from blood cells. Recent advancements in rare-cell technology have provided solutions to the once daunting task of isolating extremely rare CTCs in the blood of cancer patients. This book presents different novel approaches for detection and purification of CTCs. In addition, the readers are introduced to new technologies for molecular profiling of CTCs, including techniques to overcome limitations posed by the paucity of cells and the biomolecules available for downstream molecular analysis. This book is particularly relevant to scientists and academicians who are interested in the field of CTC research. It provides an overview of the recent technological advances in CTC isolation and profiling. This work also includes discussions on pertinent issues regarding the biology of CTCs, and their potential utility as liquid biopsy for personalized medicine. We hope that this book stimulate further research and help advance our understanding of the molecular biology of CTCs.
ISBN: 9783319559476$q(electronic bk.)
Standard No.: 10.1007/978-3-319-55947-6doiSubjects--Topical Terms:
345769
Metastasis.
LC Class. No.: RC269.5
Dewey Class. No.: 616.99407
Isolation and molecular characterization of circulating tumor cells
LDR
:03545nmm a2200325 a 4500
001
514850
003
DE-He213
005
20170530142439.0
006
m d
007
cr nn 008maaau
008
180126s2017 gw s 0 eng d
020
$a
9783319559476$q(electronic bk.)
020
$a
9783319559469$q(paper)
024
7
$a
10.1007/978-3-319-55947-6
$2
doi
035
$a
978-3-319-55947-6
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC269.5
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.99407
$2
23
090
$a
RC269.5
$b
.I85 2017
245
0 0
$a
Isolation and molecular characterization of circulating tumor cells
$h
[electronic resource] /
$c
edited by Mark Jesus M. Magbanua, John W. Park.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2017.
300
$a
xvi, 301 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
v.994
505
0
$a
Preface -- Circulating Tumor Cells as Cancer Biomarkers -- Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells -- Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics -- Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors -- Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis -- Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration -- Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype -- Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures -- Detection of Gene-Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer -- Enrichment, Isolation, and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells -- Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
520
$a
The past decade has seen remarkable progress in elucidating the clinical relevance of circulating tumor cells (CTCs) Evidence from numerous clinical studies has unequivocally demonstrated the importance of CTCs as harbingers of poor outcome. Despite these advances, the molecular nature of CTCs remains elusive. This is in part due to the difficulty in isolating pure CTCs away from blood cells. Recent advancements in rare-cell technology have provided solutions to the once daunting task of isolating extremely rare CTCs in the blood of cancer patients. This book presents different novel approaches for detection and purification of CTCs. In addition, the readers are introduced to new technologies for molecular profiling of CTCs, including techniques to overcome limitations posed by the paucity of cells and the biomolecules available for downstream molecular analysis. This book is particularly relevant to scientists and academicians who are interested in the field of CTC research. It provides an overview of the recent technological advances in CTC isolation and profiling. This work also includes discussions on pertinent issues regarding the biology of CTCs, and their potential utility as liquid biopsy for personalized medicine. We hope that this book stimulate further research and help advance our understanding of the molecular biology of CTCs.
650
0
$a
Metastasis.
$3
345769
650
1 4
$a
Biomedicine.
$3
273648
650
2 4
$a
Cancer Research.
$3
273660
700
1
$a
Magbanua, Mark Jesus M.
$3
785048
700
1
$a
Park, John W.
$3
785049
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
557559
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-55947-6
950
$a
Biomedical and Life Sciences (Springer-11642)
based on 0 review(s)
ALL
電子館藏
Items
1 records • Pages 1 •
1
Inventory Number
Location Name
Item Class
Material type
Call number
Usage Class
Loan Status
No. of reservations
Opac note
Attachments
000000143613
電子館藏
1圖書
電子書
EB RC269.5 I85 2017
一般使用(Normal)
On shelf
0
1 records • Pages 1 •
1
Multimedia
Multimedia file
http://dx.doi.org/10.1007/978-3-319-55947-6
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login